Suboxone and methadone in Louisiana: methadone clinic or office-based care?
Most people in Louisiana who want medication for opioid use disorder end up choosing between two very different kinds of care. One is a methadone clinic, which federal law calls an opioid treatment program (OTP). The other is a doctor's office, clinic or telehealth practice that prescribes buprenorphine (Suboxone and its generics) to fill at a pharmacy. This guide compares the two, then covers what Louisiana Medicaid pays for, the federal rule changes that make starting easier, and what to do if you have no insurance.
Louisiana Recovery Guide is operated by Treatment Outreach, an independent service. Treatment Outreach does not prescribe or dispense medication, and nothing here is medical advice. A licensed clinician decides which medication, if any, is right for you.
If someone may be overdosing, call 911. For a mental health or substance use crisis, call or text 988.
The three medications, in plain terms
The FDA has approved three medications for opioid use disorder: methadone, buprenorphine and naltrexone. SAMHSA describes them this way:
- Methadone is a long-acting full opioid agonist and a Schedule II controlled medication. When it is used to treat opioid use disorder, it can only be dispensed through a SAMHSA-certified OTP.
- Buprenorphine is a partial opioid agonist. SAMHSA notes it was the first opioid use disorder medication that could be prescribed or dispensed in a physician's office. Suboxone combines buprenorphine with naloxone; there are also tablets, films and long-acting injections.
- Naltrexone is not an opioid and is not addictive. For opioid use disorder, the extended-release injection (Vivitrol) is given about once a month, and SAMHSA says people should wait at least 7 days after short-acting opioids, and 10 to 14 days after long-acting ones, before starting it.
SAMHSA describes each medication as one part of a treatment plan that also includes counseling and other support.
Methadone clinic vs. office-based care at a glance
| Methadone clinic (OTP) | Office-based buprenorphine | |
|---|---|---|
| Medications | Methadone; many OTPs also dispense buprenorphine and naltrexone | Buprenorphine (and naltrexone) |
| How you get the dose | Dispensed at the clinic, with take-home doses added over time | Prescription filled at a pharmacy |
| Structure | Frequent visits, counseling and drug testing built in | Visit schedule set by the prescriber |
| Who can provide it | Only a SAMHSA-certified, state-licensed OTP | Any practitioner with a standard DEA registration covering Schedule III, if state law allows |
| Telehealth start | Methadone: video evaluation allowed at the OTP, not audio-only | Buprenorphine: audio-only or video, under DEA rules |
Neither route is "better" for everyone. People who want daily structure, or who have not done well on buprenorphine, often look at OTPs. People who need to keep a work schedule, or who live far from a clinic, often start with an office or telehealth prescriber. A clinician can talk through the trade-offs with you.
How methadone clinics work in Louisiana
Fewer clinics than many states. SAMHSA's Opioid Treatment Program Directory listed 11 certified OTPs in Louisiana when we checked on November 18, 2026, in Alexandria, Baton Rouge, Breaux Bridge, Gretna, Hammond, Houma, LaPlace, Lake Charles, Monroe, New Orleans and Shreveport. Check the directory for current listings, because programs open and close.
Why there are not more. In its report responding to House Concurrent Resolution 71 of the 2019 legislative session, the Louisiana Department of Health (LDH) explained that a 2001 law put a moratorium on new methadone licenses through July 1, 2010. Since then, LDH may license a new OTP only after it conducts a need review for a geographic area and issues a request for applications. That report counted 10 OTPs open as of 2020, at least one in each of LDH's nine administrative regions.
Who oversees them. According to LDH, Louisiana's OTPs are privately owned, licensed by the LDH Health Standards Section and the Board of Pharmacy, accredited by a SAMHSA-approved body, and approved by SAMHSA and the DEA. The State Opioid Treatment Authority, a staff member of LDH's Office of Behavioral Health, provides programmatic oversight. Louisiana Medicaid's OTP rules say exceptions to take-home limits must be approved by the State Opioid Treatment Authority, and that OTPs use a Methadone Central Registry.
What the first visits involve. Louisiana Medicaid's provider manual for OTP services describes a screening, an examination by the OTP's physician practitioner before admission, and a full medical exam, including lab results, within 14 days of admission. Counseling is part of the program. Ask the clinic what to bring and how long the first day takes.
Take-home doses. A federal rule (42 CFR Part 8, updated in 2024) lets OTPs give up to 7 take-home doses in the first 14 days of treatment, up to 14 from day 15, and up to 28 from day 31, based on the OTP practitioner's judgment. Louisiana's own rules and the program's policies also apply, so your schedule may be different.
How office-based and telehealth buprenorphine works
You no longer need to find a specially "waivered" doctor. SAMHSA explains that Section 1262 of the Consolidated Appropriations Act, 2023 removed the federal waiver requirement. Any practitioner with a current DEA registration that includes Schedule III authority may prescribe buprenorphine for opioid use disorder, if state law permits. Because the waiver list no longer exists, SAMHSA's buprenorphine practitioner search was retired in 2026, so use FindTreatment.gov or ask your own doctor.
For telehealth, the DEA extended its pandemic-era flexibilities through December 31, 2026. Separately, a DEA and HHS final rule on buprenorphine by telemedicine lets a practitioner prescribe an initial six-month supply, including by audio-only visit, after checking the prescription drug monitoring program. After that, further prescriptions need an in-person evaluation or another lawful telemedicine route. These rules are changing, so ask any telehealth program how it handles visits in 2027.
What Louisiana Medicaid covers
Louisiana Medicaid (Healthy Louisiana) adopted a rule, published in January 2020, to cover medication-assisted treatment in OTPs, including methadone, for Medicaid-eligible adults and children with opioid use disorder. Louisiana's Medicaid state plan says medication-assisted treatment is covered for all beneficiaries who meet medical necessity criteria, and that the state covers all FDA-approved forms of naltrexone, buprenorphine and methadone for this purpose.
Coverage still has rules. Louisiana Medicaid's OTP manual notes that non-preferred forms of buprenorphine and buprenorphine/naloxone need prior authorization, and OTPs bill through the health plans they contract with. Ask your plan or the clinic which products and providers are in network. Our Healthy Louisiana guide explains applying and appeals, and our insurance guide covers private plans.
No insurance?
Start with the local governing entity (LGE) for your parish, the public behavioral health authority that LDH lists by region. Our guide to getting into rehab in Louisiana explains how LGEs work. SAMHSA's National Helpline (1-800-662-4357) is free and confidential and can refer uninsured callers to state-funded programs. Many OTPs also offer self-pay rates; ask what is included in the weekly fee.
Overdose risk if you stop
Tolerance drops quickly after someone stops opioids, including after stopping methadone or buprenorphine, leaving a program or getting out of jail. Keep naloxone nearby. Our Louisiana naloxone guide explains where to get it free. If you are deciding on a level of care beyond medication, see our levels of care overview, and for family members, our guide to helping a loved one.
Frequently asked questions
How many methadone clinics are there in Louisiana?
SAMHSA's OTP Directory listed 11 certified opioid treatment programs in Louisiana on November 18, 2026. New programs require an LDH need review before they can be licensed, so the number changes slowly.
Does Louisiana Medicaid pay for Suboxone?
Louisiana's Medicaid state plan covers FDA-approved forms of buprenorphine for opioid use disorder when medically necessary. Non-preferred products need prior authorization, so ask your health plan which products are preferred.
Can I start buprenorphine by telehealth in Louisiana?
Under DEA rules in effect through December 31, 2026, many practitioners can start buprenorphine by telehealth, including audio-only. A separate final rule allows an initial six-month supply by telemedicine. The practitioner must also follow Louisiana law.
Can I get methadone at a regular pharmacy?
No. When methadone is used to treat opioid use disorder, it can only be dispensed through a SAMHSA-certified opioid treatment program.
Does Louisiana Recovery Guide prescribe medication?
No. This site is run by Treatment Outreach, which does not prescribe or dispense medication. Calls are answered by Treatment Outreach's team on behalf of partner treatment facilities.
Sources
- SAMHSA, Methadone: https://www.samhsa.gov/substance-use/treatment/options/methadone
- SAMHSA, Buprenorphine: https://www.samhsa.gov/substance-use/treatment/options/buprenorphine
- SAMHSA, Naltrexone: https://www.samhsa.gov/substance-use/treatment/options/naltrexone
- SAMHSA, Waiver Elimination (MAT Act): https://www.samhsa.gov/substance-use/treatment/statutes-regulations-guidelines/mat-act
- FDA, Information about Medications for Opioid Use Disorder: https://www.fda.gov/drugs/information-drug-class/information-about-medications-opioid-use-disorder-moud
- Federal Register, Medications for the Treatment of Opioid Use Disorder (42 CFR Part 8 final rule, Feb. 2, 2024): https://www.federalregister.gov/documents/2024/02/02/2024-01693/medications-for-the-treatment-of-opioid-use-disorder
- DEA, DEA Extends Telemedicine Flexibilities (Dec. 31, 2025): https://www.dea.gov/press-releases/2025/12/31/dea-extends-telemedicine-flexibilities-ensure-continued-access-care
- Federal Register, Expansion of Buprenorphine Treatment via Telemedicine Encounter (Jan. 17, 2025): https://www.federalregister.gov/documents/2025/01/17/2025-01049/expansion-of-buprenorphine-treatment-via-telemedicine-encounter
- SAMHSA, Opioid Treatment Program Directory (Louisiana, accessed Nov. 18, 2026): https://www.samhsa.gov/find-help/locators/opioid-treatment-program-directory
- Louisiana Department of Health, Response to HCR 71 of the 2019 Regular Session (opioid treatment programs): https://ldh.la.gov/assets/docs/LegisReports/HCR71RS201912021.pdf
- Louisiana Department of Health, Rule: Treatment for Opioid Use Disorder in Opioid Treatment Programs (LAC 50:XXXIII.Chapters 151-157): https://www.ldh.la.gov/assets/medicaid/Rulemaking/FinalRules/January2020FinalRules.pdf
- Louisiana Medicaid State Plan, Medication Assisted Treatment (TN 25-0020): https://ldh.la.gov/assets/medicaid/StatePlan/Sec3/Attachment3.1-A_Supplement4_Medication-AssistedTreatment.pdf
- Louisiana Medicaid, Behavioral Health Services Provider Manual, Addiction Services: Opioid Treatment Programs: https://ldh.la.gov/assets/medicaid/PC-PM/05_05_25/2025-BHS-3_2.4_Addiction_Services_OTP_04.24.25.pdf
- Louisiana Department of Health, Local Governing Entities: https://ldh.la.gov/page/local-governing-entities
- SAMHSA National Helpline: https://www.samhsa.gov/find-help/helplines/national-helpline
- FindTreatment.gov: https://findtreatment.gov
- 988 Suicide & Crisis Lifeline: https://988lifeline.org